News Athena Bioscience Announces Launch of Nexiclon™ XR, the Only Once-Daily Clonidine Extended-Release Tablets for Treatment of Hypertension March 3, 2022 Athena Bioscience Cardiovascular Product Portfolio to be Promoted by Sabal Therapeutics February 22, 2022